Statistics
Publications
12
Citations
1.2K
H-Index
12
Active since
2006
Michael H. Brave is an author at United States Food and Drug Administration specializing in medicine, oncology, and pharmacology.
Publications per year
2006–2024
12
12
FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease–Associated Tumors
Jaleh Fallah, Michael H. Brave, Chana Weinstock et al. · Clinical Cancer Research · 2022 · 171 citations · Full text
Medicine, Oncology, Pharmacology +16
Michael H. Brave, Ann T. Farrell, Sue Ching Lin et al. · Oncology · 2010 · 143 citations
Medicine, Hematology, Pharmacology +17
1–5 of 12